Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Survival Analysis of Treatment Efficacy in Comparative Coronavirus Disease 2019 Studies

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1563Source: DataRank Database

Survival Analysis of Treatment Efficacy in Comparative Coronavirus Disease 2019 Studies is a research paper published in Clinical Infectious Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.10)OA: bronzeTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Lü Tian ORCID,Dae Hyun Kim ORCID,A. Russell Localio ORCID,L. J. Wei ORCID,Zachary R. McCaw ORCID

Live enrichment

PubMed:33053155 PMC:PMC7665361 OpenAlex:https://openalex.org/W3093016888

National Institutes of Health

Grant: R21AG060227

National Institutes of Health

Grant: R01 HL089778

National Institutes of Health

Grant: 5R01HL089778-11

Precision Medicine by Harmonizing Real World Evidence and RCT Data

National Institutes of Health

Grant: 5R21AG060227-02

Restricted Mean Survival Time to Interpret Clinical Trials for Treatment Decision-Making in Older Adults

FWCI

0.10

Citation Percentile

0.5%

Citation Trend

2020

2021

2022

2025

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/cid/article-pdf/72/11/e887/38389443/ciaa1563.pdf

publisherhttps://academic.oup.com/cid/article-pdf/72/11/e887/38389443/ciaa1563.pdf

publisherhttp://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1563/34144691/ciaa1563.pdf

publisherhttp://academic.oup.com/cid/article-pdf/72/11/e887/38389443/ciaa1563.pdf

journalhttps://doi.org/10.1093/cid/ciaa1563

Fields of Study

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19COVID-19 and healthcare impacts03 medical and health sciences0302 clinical medicine

MeSH Terms

COVID-19SARS-CoV-2HumansProportional Hazards ModelsSurvival AnalysisTreatment Outcome

Keywords

MedicineCoronavirus disease 2019 (COVID-19)Coronavirus2019-20 coronavirus outbreakPandemicBetacoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineDiseaseVirologyCoronavirus InfectionsInfectious disease (medical specialty)Internal medicineOutbreakSurvival rateDexamethasoneCritical CareHazard RatioMean Survival TimeMicrobiology (medical)Infectious DiseasesTreatment OutcomeSARS-CoV-2COVID-19HumansSurvival AnalysisProportional Hazards Models

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being